|

Semaglutide (Wegovy) weekly injection Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2: 1

Top Sponsors

  • Veru Inc.1

Indications

  • HOMA-IR1
  • Mobility Disability1
  • Obesity & Overweight1
  • Weight Loss1

Phoenix, Arizona1 trial

Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight Loss

DM Clinical Research - Phoenix

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.